Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FL78R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,468
Award facts
- Contract value 100% obligated
- $18,467.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,467.94 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injectors on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Zepbound is a prescription medication used in diabetes and weight management treatment. Through its comprehensive IDC vehicle, AmerisourceBergen provides a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FL78R?
SPE2DB25FL78R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FL78R worth?
The government has obligated $18,468 on SPE2DB25FL78R.
Is contract SPE2DB25FL78R an order under another contract?
Yes. SPE2DB25FL78R is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB25FL78R competed?
The extent of competition for SPE2DB25FL78R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award